Table 1 Demographics and clinical characteristics of the included prostate cancer patients (n = 229)
Characteristics | Number (%) |
|---|---|
Age (years) | 68.2 ± 6.5 |
BMI (kg/m2) | 23.9 ± 2.8 |
Preoperative PSA (ng/ml) (IQR) | 10.6 (7.8, 17.6) |
Smoking history (%) | |
 None | 144 (62.9%) |
 Former | 42 (18.3%) |
 Current | 43 (18.8%) |
Prostate size (cm3) (IQR) | 39.9 (27.4, 45.1) |
Prior/Previous surgeries | |
 abdominal surgery | 37 (16.2%) |
 pelvic surgery | 35 (15.3%) |
 hernia surgery | 16 (7.0%) |
Biopsy Gleason score | |
 6 | 72 (32.9%) |
 7 | 83 (37.9%) |
  ≥ 8 | 64 (29.2%) |
Clinical stage | |
 cT1 | 41 (21.9%) |
 cT2 | 129 (69.0%) |
 cT3 | 16 (8.6%) |
 cT4 | 1 (0.5%)a |
NCCN risk group | |
 Low risk | 31 (16.8%) |
 Favorable intermediate | 35 (19.0%) |
 Unfavorable intermediate | 41 (22.3%) |
 High/very high risk | 77 (41.8%) |
Charlson comorbidity index | |
  < 2 | 220 (96.1%) |
  ≥ 2 | 9 (3.9%) |
ASA score | |
  ≤ 2 | 209 (91.3%) |
  > 2 | 20 (8.7%) |